Almirall is a Spain-based pharmaceutical company that develops proprietary medicines for the treatment of diseases including psoriasis and topic dermatitis across the globe.
Business Model:
Revenue: $923.2M
Employees: 1,001-5,000
Almirall was acquired by
AstraZeneca.
The acquisition happend on 2014-07-30.
Details of the transaction were not public
Address: Ronda General Mitre 151
City: Barcelona
State: catalonia
Zip: 08022
Country: ES
Almirall is a Spain-based pharmaceutical company that develops proprietary medicines for the treatment of diseases including psoriasis and topic dermatitis across the globe.
Contact Phone:
+12128166638
Contact Email:
Listed Exchange:
BME Spanish Exchanges
Ticker Symbol:
ALM
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2020 | Ancora | Grant | 56.1k |
7/2015 | Suneva Medical | Series C | 15M |
1/2020 | Ancora | Grant | 0 |
7/2015 | Suneva Medical | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2019 | IPO | - | 6/2019 | Debt | $136.6M |
European Investment Bank |
6/2019 | IPO | - |
|
---|
Announced Date | Name | Price |
---|---|---|
1/2020 | Bioniz Therapeutics | |
12/2013 | Aqua Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|